期刊文献+

诺仕帕联合速尿治疗输尿管结石的临床分析

Clinical analysis of No-Spa and Lasix in the treatment of ureteral stones
下载PDF
导出
摘要 目的研究诺仕帕联合速尿治疗输尿管下段结石的疗效。方法将60例输尿管结石患者随机分为实验组和对照组。实验组给予速尿联合诺仕帕以及抗生素口服,对照组给予抗生素口服,治疗期为10天。结果 10天内80%(48/60)的患者排出结石。有效率实验组为93.3%(28/30),对照组为66.7%(20/30)。平均排石时间:实验组为5.3天,对照组为9.2天。实验组无病例发生肾绞痛,对照组有5例发生肾绞痛。两组比较差异有统计学意义(P<0.05)。结论诺仕帕与速尿合用能够安全、有效地提高输尿管结石的排出率。 Objective To investigate the efficacy of No-Spa and lasix for the treatment of patients with ureteral stones. Methods A total of 60 patients with stones located in the ureter were randomly divided into 2 groups ( 30 cases in each group) . Group 1 received lasix, No-Spa and antibiotics, group 2 received antibiotics only. All patients were observe for 10 days. Results In 10 days, expulsion of stone was observe in 48 cases (80%) ; group 1 was 93.3% (28/ 30), group 2 was 66. 7% (20/30) . The mean expulsion time of group 1 and 2 was 5.3 days and 9. 2 days. The renal colic within 10 days were recurred in group 1 of 0, group 2 of 5 . There was statistically significant between group 1 and group 2. Conclusion It is demonstrated that No-Spa combines lasix are safe and effective for the treatment of ureteral stones.
出处 《广州医药》 2012年第3期22-23,共2页 Guangzhou Medical Journal
关键词 输尿管结石 诺仕帕 速尿 Ureteral calculi No-Spa Lasix
  • 相关文献

参考文献7

  • 1Ktipeli B, Alkibay T, Sinik Z, et al. What is the optimal treatment for lower ureteral stones larger than 1 cm?[J] . Int J Urol, 2000, 7 (5) : 167-171.
  • 2Ohgaki K, Horiuchi K, Hikima N, et al. Facilitation of expulsion of ureteral stones by addition of otl-blockers to conservative therapy [ J] . Scand J Urol Nephrol, 2010, (6): 420-424.
  • 3Azm TA, Higazy H. Effect of diuresis on extracorporeal shockwave lithotripsy treatment of ureteric calculi [ J] . Scand J Urol Nephrol, 2002, 36 (3) : 209-212.
  • 4E1-Shiekh R, Zahran F, EI-Fetouh Gouda AA. Spectro- photometric determination of some anti-tussive and anti- spasmodic drugs through ion-pair complex formation with thiocyanate and cobalt (II) or molybdenum (V) [ J] . Spectrochim Acta A Mol Biomol Spectrosc, 2007, 66 (4-5) : 1279-1287.
  • 5Dyderski S, Grzeokowiak E, Drobnik L, et al. Bioavail- ability study of drotaverine from capsule and tablet prepa- rations in healthy volunteers [ J ] . Arzneimittelforschung, 2004, 54 (5): 298-302.
  • 6Dash A, Maiti R, Akantappa Bandakkanavar TK, et al. Intramuscular drotaverine and diclofenac in acute re- nal colic: a comparative study of analgesic efficacy and safety [J] . Pain Med, 2012-02-01. doi: 10.1111/j. 1526-4637. 2011. 01314. X.
  • 7Tomoskozi Z, Finance O, Aranyi P. Drotaverine interacts with the L-type Ca (2 + ) channel in pregnant rat uterine membranes [J] . Eur J Pharmacol, 2002, 449 (1-2): 55 -60.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部